RESULTS : Carrier frequency of the MLH1 -93 variant was higher in patients who developed therapy related acute myeloid leukaemia ( t-AML ) ( 75.0 % , n = 12 ) or breast cancer ( 53.3 % .
O O O O O O B-GeneOrGeneProduct O O O O O B-OrganismTaxon O O O O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O I-DiseaseOrPhenotypicFeature O O O O O O O O O O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O O O O